| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 50.269 | 56.715 | 61.442 | 73.543 |
| Total Income - EUR | - | - | - | - | - | - | 50.269 | 56.715 | 61.442 | 73.543 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.683 | 597 | 13.521 | 25.261 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 48.586 | 56.118 | 47.921 | 48.282 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 47.078 | 54.621 | 42.111 | 46.186 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Gabrianmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25 | 25 | 30.602 | 22.862 |
| Current Assets | - | - | - | - | - | - | 47.648 | 72.567 | 55.446 | 76.228 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 30.013 | 45.613 | 55.446 | 68.095 |
| Cash | - | - | - | - | - | - | 17.635 | 26.954 | 0 | 8.132 |
| Shareholders Funds | - | - | - | - | - | - | 47.119 | 69.035 | 42.160 | 43.657 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 555 | 3.557 | 44.462 | 56.004 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gabrianmed S.r.l.